Financial Year |
March 31 2023 |
Monetary Funds |
5,120,140,209.50 |
Held-for-trading Financial Assets |
200,000,000.00 |
Notes Receivable |
123,578,643.11 |
Accounts Receivable |
5,865,680,594.11 |
Advances to Suppliers |
198,897,980.32 |
Other Receivables |
94,307,362.17 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
49,480,455.08 |
Inventories |
148,495,416.37 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
564,765,168.12 |
Total Current Assets |
12,610,505,234.89 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
1,664,186.71 |
Long-term Equity Investment |
3,506,377,545.77 |
Investment Properties |
24,650,740.93 |
Fixed Assetes |
32,294,694,483.43 |
Under-construction Projects |
20,368,031,963.65 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,118,338,982.90 |
R&D expenses |
28,654,114.09 |
Goodwill |
96,922,283.74 |
Long-Term Deferred and Prepaid Expenses |
40,192,108.76 |
Deferred Income Tax Assets |
197,885,558.60 |
Other Non-Current Assets |
2,393,851,404.42 |
Sub-Total of Non-Current Assets |
63,110,939,523.87 |
Total Assets |
75,721,444,758.76 |
Short-Term Loans |
1,541,043,899.26 |
Trading Financial liabilities |
-- |
Notes Payable |
6,228,139.79 |
Accounts Payable |
346,024,865.02 |
Accounts Received In Advance |
1,161,061,946.88 |
Employee Compensation Payable |
32,539,417.74 |
Taxes Payable |
268,298,823.07 |
Interest Payable |
-- |
Dividend Payable |
55,316,732.57 |
Other payables |
7,371,677,313.22 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,642,059,012.50 |
Other Current Liabilities |
746,835,755.77 |
Sub-Total of Current Liabilities |
16,175,493,538.48 |
Long-term Loans |
30,717,657,047.56 |
Bonds Payable |
1,500,000,000.00 |
Long-Term Accounts Payable |
174,192,773.38 |
Special Payable |
-- |
Estimatied Liabilities |
77,531,149.68 |
Deferred Income Tax Liabilities |
72,331,874.23 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
33,313,001,192.36 |
Total Liabilities |
49,488,494,730.84 |
Paid-In Capital(Or Share Stock) |
4,187,093,073.00 |
Capital Surplus |
6,582,283,444.08 |
Surplus Reserve |
827,179,319.36 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
8,655,176,805.56 |
Minority Stockholder's Interest |
4,913,009,620.67 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,319,940,407.25 |
Owner's Equity(Stockholder's Equity) |
26,232,950,027.92 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
75,721,444,758.76 |